“I’m looking through you”: What consumers and manufacturers need to know about non-invasive diagnostic tests for endometriosis

In: Journal of Endometriosis and Uterine Disorders · 2023 · vol. 2 , pp. 100031 · doi:10.1016/j.jeud.2023.100031 · W4380087970
article OA: diamond CC0 ⤵ 5 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-06

This paper discusses the upcoming rise of non-invasive endometriosis diagnostics for screening, warning of potential overdiagnosis and overtreatment in asymptomatic individuals.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Consequences of the shift from the use of non-invasive testing for diagnosis to screening purposes • As the high-throughput screening and sequencing become increasingly faster and affordable, that there will be a swell of commercial non-invasive diagnostic tests for endometriosis in the coming years to fill the void. • Overdiagnosis is common when introducing a novel diagnostic test and overdiagnosis leads to overtreatment that provides, by definition, no benefit at all but that can cause harm and incur expenses. • The shift from the use of non-invasive testing for diagnostic purposes (i.e.use in symptomatic women) to screening purposes (i.e., use in asymptomatic women) is very likely. • In presence of pain symptoms, endometriosis must be promptly suspected and clinically diagnosed regardless of imaging findings and non-invasive diagnostic testing.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (36)

Cited by (5)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK